Mubadala Investment Co PJSC

Insider Buys Quantity –
43
2023-03-02PurchaseRecursion Pharmaceuticals, Inc.
RXRX
10 percent owner
66,822
0.034%
$7.82$522,354+1.44%
2023-03-01PurchaseRecursion Pharmaceuticals, Inc.
RXRX
10 percent owner
48,867
0.0255%
$7.94$388,082+2.14%
2023-02-28PurchaseRecursion Pharmaceuticals, Inc.
RXRX
10 percent owner
815
0.0004%
$7.97$6,496-0.86%
2023-02-27PurchaseRecursion Pharmaceuticals, Inc.
RXRX
10 percent owner
52,500
0.0273%
$7.69$403,725+4.66%
2023-02-24PurchaseRecursion Pharmaceuticals, Inc.
RXRX
10 percent owner
109,118
0.0572%
$7.64$833,552+5.26%
2023-02-23PurchaseRecursion Pharmaceuticals, Inc.
RXRX
10 percent owner
51,864
0.0268%
$7.79$403,792+1.78%
2023-02-22PurchaseRecursion Pharmaceuticals, Inc.
RXRX
10 percent owner
50,941
0.0262%
$7.83$399,016+0.25%
2023-02-21PurchaseRecursion Pharmaceuticals, Inc.
RXRX
10 percent owner
94,418
0.0495%
$7.74$731,126+3.05%
2023-02-17PurchaseRecursion Pharmaceuticals, Inc.
RXRX
10 percent owner
63,382
0.0319%
$7.71$488,986-0.88%
2023-02-16PurchaseRecursion Pharmaceuticals, Inc.
RXRX
10 percent owner
42,682
0.0225%
$7.90$337,043+1.41%
2023-02-14PurchaseRecursion Pharmaceuticals, Inc.
RXRX
10 percent owner
6,300
0.0031%
$7.95$50,060-5.34%
2023-02-13PurchaseRecursion Pharmaceuticals, Inc.
RXRX
10 percent owner
32,474
0.0169%
$7.97$258,837-1.19%
2023-02-10PurchaseRecursion Pharmaceuticals, Inc.
RXRX
10 percent owner
11,000
0.0056%
$7.98$87,808-4.15%
2023-02-01PurchaseRecursion Pharmaceuticals, Inc.
RXRX
10 percent owner
600
0.0003%
$7.97$4,782-7.78%
2023-02-01PurchaseRecursion Pharmaceuticals, Inc.
RXRX
10 percent owner
1,200
0.0006%
$7.97$9,564-7.78%
2023-01-26PurchaseRecursion Pharmaceuticals, Inc.
RXRX
director
7,886
0.004%
$7.99$63,006-3.72%
2023-01-26PurchaseRecursion Pharmaceuticals, Inc.
RXRX
director
15,772
0.008%
$7.99$126,012-3.72%
2023-01-25PurchaseRecursion Pharmaceuticals, Inc.
RXRX
director
24,526
0.0123%
$7.88$193,267-4.08%
2023-01-25PurchaseRecursion Pharmaceuticals, Inc.
RXRX
director
49,052
0.0245%
$7.88$386,535-4.08%
2023-01-10PurchaseRecursion Pharmaceuticals, Inc.
RXRX
director
69,518
0.036%
$7.72$536,846+1.22%
Stocks ScreenerTop-50 StocksInsiders ScreenerList of All Stocks
About Prismo.proPrivacy PolicyTerms of ServiceContact Us